257 related articles for article (PubMed ID: 33374388)
1. IBS-Symptoms in IBD Patients-Manifestation of Concomitant or Different Entities.
Szałwińska P; Włodarczyk J; Spinelli A; Fichna J; Włodarczyk M
J Clin Med; 2020 Dec; 10(1):. PubMed ID: 33374388
[TBL] [Abstract][Full Text] [Related]
2. Predictors of irritable bowel syndrome-like symptoms in quiescent inflammatory bowel disease.
Ahmed M; Pu A; Jencks K; Bishu S; Higgins P; Chey WD; Rao K; Lee A
Neurogastroenterol Motil; 2024 Jun; 36(6):e14809. PubMed ID: 38651743
[TBL] [Abstract][Full Text] [Related]
3. Negative Effects on Psychological Health and Quality of Life of Genuine Irritable Bowel Syndrome-type Symptoms in Patients With Inflammatory Bowel Disease.
Gracie DJ; Williams CJ; Sood R; Mumtaz S; Bholah MH; Hamlin PJ; Ford AC
Clin Gastroenterol Hepatol; 2017 Mar; 15(3):376-384.e5. PubMed ID: 27189912
[TBL] [Abstract][Full Text] [Related]
4. Comparison of geographic distributions of Irritable Bowel Syndrome with Inflammatory Bowel Disease fail to support common evolutionary roots: Irritable Bowel Syndrome and Inflammatory Bowel Diseases are not related by evolution.
Szilagyi A; Xue X
Med Hypotheses; 2018 Jan; 110():31-37. PubMed ID: 29317064
[TBL] [Abstract][Full Text] [Related]
5. Calprotectin Is a Useful Tool in Distinguishing Coexisting Irritable Bowel-Like Symptoms from That of Occult Inflammation among Inflammatory Bowel Disease Patients in Remission.
Jelsness-Jørgensen LP; Bernklev T; Moum B
Gastroenterol Res Pract; 2013; 2013():620707. PubMed ID: 23476638
[TBL] [Abstract][Full Text] [Related]
6. The prevalence of irritable bowel syndrome-type symptoms in inflammatory bowel disease patients in remission.
Hoekman DR; Zeevenhooven J; D'Haens GR; Benninga MA
Eur J Gastroenterol Hepatol; 2017 Sep; 29(9):1086-1090. PubMed ID: 28639969
[TBL] [Abstract][Full Text] [Related]
7. Functional bowel symptoms in quiescent inflammatory bowel diseases: role of epithelial barrier disruption and low-grade inflammation.
Vivinus-Nébot M; Frin-Mathy G; Bzioueche H; Dainese R; Bernard G; Anty R; Filippi J; Saint-Paul MC; Tulic MK; Verhasselt V; Hébuterne X; Piche T
Gut; 2014 May; 63(5):744-52. PubMed ID: 23878165
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic Implications of Irritable Bowel Syndrome Is an Independent Risk Factor for Undergoing Surgical Interventions in Patients with Inflammatory Bowel Disease.
Fu Y; Waghray N; Fass R; Song G
Diagnostics (Basel); 2023 May; 13(11):. PubMed ID: 37296752
[TBL] [Abstract][Full Text] [Related]
9. [Emotional and personality features of patients with irritable bowel syndrome and bowel inflammatory diseases].
Mnatsakanyan MG; Dyukova GM; Pogromov AP; Tashchyan OV
Klin Med (Mosk); 2016; 94(10):764-9. PubMed ID: 30299020
[TBL] [Abstract][Full Text] [Related]
10. Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease.
D'Haens G; Ferrante M; Vermeire S; Baert F; Noman M; Moortgat L; Geens P; Iwens D; Aerden I; Van Assche G; Van Olmen G; Rutgeerts P
Inflamm Bowel Dis; 2012 Dec; 18(12):2218-24. PubMed ID: 22344983
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of symptoms meeting criteria for irritable bowel syndrome in inflammatory bowel disease: systematic review and meta-analysis.
Halpin SJ; Ford AC
Am J Gastroenterol; 2012 Oct; 107(10):1474-82. PubMed ID: 22929759
[TBL] [Abstract][Full Text] [Related]
12. Fecal M2-pyruvate kinase (M2-PK): a novel marker of intestinal inflammation.
Chung-Faye G; Hayee B; Maestranzi S; Donaldson N; Forgacs I; Sherwood R
Inflamm Bowel Dis; 2007 Nov; 13(11):1374-8. PubMed ID: 17577247
[TBL] [Abstract][Full Text] [Related]
13. The prevalence of irritable bowel syndrome-type symptoms in paediatric inflammatory bowel disease, and the relationship with biochemical markers of disease activity.
Diederen K; Hoekman DR; Hummel TZ; de Meij TG; Koot BG; Tabbers MM; Vlieger AM; Kindermann A; Benninga MA
Aliment Pharmacol Ther; 2016 Jul; 44(2):181-8. PubMed ID: 27110920
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of irritable bowel syndrome-type symptoms in patients with inflammatory bowel disease in remission: a systematic review and meta-analysis.
Fairbrass KM; Costantino SJ; Gracie DJ; Ford AC
Lancet Gastroenterol Hepatol; 2020 Dec; 5(12):1053-1062. PubMed ID: 33010814
[TBL] [Abstract][Full Text] [Related]
15. Faecal calprotectin as a novel biomarker for differentiating between inflammatory bowel disease and irritable bowel syndrome.
Chang MH; Chou JW; Chen SM; Tsai MC; Sun YS; Lin CC; Lin CP
Mol Med Rep; 2014 Jul; 10(1):522-6. PubMed ID: 24788223
[TBL] [Abstract][Full Text] [Related]
16. [Increased IgE-type antibody response to food allergens in irritable bowel syndrome and inflammatory bowel diseases].
Mekkel G; Barta Z; Ress Z; Gyimesi E; Sipka S; Zeher M
Orv Hetil; 2005 Apr; 146(17):797-802. PubMed ID: 17918636
[TBL] [Abstract][Full Text] [Related]
17. Effect of Irritable Bowel Syndrome on Sleep Quality and Quality of Life of Inflammatory Bowel Disease in Clinical Remission.
Zargar A; Gooraji SA; Keshavarzi B; Haji Aghamohammadi AA
Int J Prev Med; 2019; 10():10. PubMed ID: 30774844
[TBL] [Abstract][Full Text] [Related]
18. A Pilot Study of Clinical Evaluation and Formation Mechanism of Irritable Bowel Syndrome-like Symptoms in Inflammatory Bowel Disease Patients in Remission.
Wang H; Zhao X; Cui X; Wang M; Jiao C; Li J; Yang Y; Li Y; Zhang H
J Neurogastroenterol Motil; 2021 Oct; 27(4):612-625. PubMed ID: 34642282
[TBL] [Abstract][Full Text] [Related]
19. Abdominal pain in patients with inflammatory bowel disease: association with single-nucleotide polymorphisms prevalent in irritable bowel syndrome and clinical management.
Ledergerber M; Lang BM; Heinrich H; Biedermann L; Begré S; Zeitz J; Krupka N; Rickenbacher A; Turina M; Greuter T; Schreiner P; Roth R; Siebenhüner A; Vavricka SR; Rogler G; Beerenwinkel N; Misselwitz B;
BMC Gastroenterol; 2021 Feb; 21(1):53. PubMed ID: 33546600
[TBL] [Abstract][Full Text] [Related]
20. Quality of life in inflammatory bowel disease in remission: the impact of IBS-like symptoms and associated psychological factors.
Simrén M; Axelsson J; Gillberg R; Abrahamsson H; Svedlund J; Björnsson ES
Am J Gastroenterol; 2002 Feb; 97(2):389-96. PubMed ID: 11866278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
